-transparent.png){kind=logo}
Data are limited on the use of serial electrophysiologic testing of drug therapy in patients with supraventricular tachycardia associated with accessory pathways, including the Wolff-Parkinson-White syndrome. Twenty-four highly symptomatic patients (aged 36 +/- 11 years) with SVT related to accessory pathways underwent electrophysiologic studies to select an effective chronic oral treatment. Conventional (verapamil, propranolol, quinidine, disopyramide) and investigational (amiodarone, aprindine, propafenone) drugs were used alone and in combination if necessary. It was determined that serial electrophysiologic studies could identify potentially effective treatments in 66% of patients with reentrant SVT involving accessory pathways, and the findings were highly predictive of long-term clinical outcome.
H M Nagi, and
S L Pinski, and
S Mokhtar, and
Y Saad, and
J D Maloney
May 1999,
Bratislavske lekarske listy,
H M Nagi, and
S L Pinski, and
S Mokhtar, and
Y Saad, and
J D Maloney
March 1993,
Pacing and clinical electrophysiology : PACE,
H M Nagi, and
S L Pinski, and
S Mokhtar, and
Y Saad, and
J D Maloney
January 1986,
Revista espanola de cardiologia,
H M Nagi, and
S L Pinski, and
S Mokhtar, and
Y Saad, and
J D Maloney
November 1984,
Pacing and clinical electrophysiology : PACE,
H M Nagi, and
S L Pinski, and
S Mokhtar, and
Y Saad, and
J D Maloney
December 1987,
American heart journal,
H M Nagi, and
S L Pinski, and
S Mokhtar, and
Y Saad, and
J D Maloney
December 1992,
Arquivos brasileiros de cardiologia,
H M Nagi, and
S L Pinski, and
S Mokhtar, and
Y Saad, and
J D Maloney
November 1986,
The American journal of cardiology,
H M Nagi, and
S L Pinski, and
S Mokhtar, and
Y Saad, and
J D Maloney
November 1997,
Cardiology clinics,
H M Nagi, and
S L Pinski, and
S Mokhtar, and
Y Saad, and
J D Maloney
July 1983,
American heart journal,
H M Nagi, and
S L Pinski, and
S Mokhtar, and
Y Saad, and
J D Maloney
May 1985,
Chest,
